Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease

被引:61
作者
Sáez-Valero, J
Costell, M
Sjögren, M
Andreasen, N
Blennow, K
Luque, JM
机构
[1] Univ Miguel Hernandez, CSIC, Inst Neurociencias, E-03550 Alicante, Spain
[2] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain
[3] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Clin Neurosci, Molndal, Sweden
[4] Karolinska Inst, NEUROTEC, Dept Clin Geriatr, Stockholm, Sweden
关键词
neurodegeneration; CSF; AD; FTD; biomarker;
D O I
10.1002/jnr.10554
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Reelin is an essential glycoprotein for correct cytoarchitectonic organization during CNS development. Its function in the adult brain is far less well understood, but altered brain and blood reelin levels have been reported in some psychiatric disorders, and the possibility has been considered of an involvement of the reelin signaling pathway in neurodegeneration. Here we report, for the first time, the presence of detectable levels of reelin in rat and human cerebrospinal fluid (CSF) and show evidence for the involvement of a 180-kDa reelin fragment in two neurodegenerative disorders. This fragment was analyzed by Western blotting in CSF samples from 13 healthy control individuals and 14 frontotemporal dementia (FTD) and 20 Alzheimer's disease (AD) patients. Increased CSF 180-kDa reelin was found in FTD (161.7 +/- 6.7 arbitrary units; a.u.) and AD (151.4 +/- 3.8 a.u.) compared with control individuals (141.4 +/- 1.2 a.u., P < 0.05). Our results strongly suggest the involvement of reelin signaling in neurodegenerative pathologies. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 35 条
  • [21] GENETIC ASSOCIATION OF THE VERY-LOW-DENSITY LIPOPROTEIN (VLDL) RECEPTOR GENE WITH SPORADIC ALZHEIMERS-DISEASE
    OKUIZUMI, K
    ONODERA, O
    NAMBA, Y
    IKEDA, K
    YAMAMOTO, T
    SEKI, K
    UEKI, A
    NANKO, S
    TANAKA, H
    TAKAHASHI, H
    OYANAGI, K
    MIZUSAWA, H
    KANAZAWA, I
    TSUJI, S
    [J]. NATURE GENETICS, 1995, 11 (02) : 207 - 209
  • [22] Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
    Patrick, GN
    Zukerberg, L
    Nikolic, M
    de la Monte, S
    Dikkes, P
    Tsai, LH
    [J]. NATURE, 1999, 402 (6762) : 615 - 622
  • [23] Role of the Reelin signaling pathway in central nervous system development
    Rice, DS
    Curran, T
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 1005 - 1039
  • [24] Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease
    SaezValero, J
    Sberna, G
    McLean, CA
    Masters, CL
    Small, DH
    [J]. LANCET, 1997, 350 (9082) : 929 - 929
  • [25] The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
    Selkoe, DJ
    [J]. TRENDS IN CELL BIOLOGY, 1998, 8 (11) : 447 - 453
  • [26] Sjogren M, 1997, INT J GERIATR PSYCH, V12, P656
  • [27] Sjögren M, 2001, CLIN CHEM, V47, P1776
  • [28] Pathophysiological aspects of frontotemporal dementia -: emphasis on cytoskeleton proteins and autoimmunity
    Sjögren, M
    Wallin, A
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (16) : 1923 - 1935
  • [29] Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells
    Smalheiser, NR
    Costa, E
    Guidotti, A
    Impagnatielle, F
    Auta, J
    Lacor, P
    Kriho, V
    Pappas, GD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) : 1281 - 1286
  • [30] The low density lipoprotein receptor gene family -: Differential expression of two α2-macroglobulin receptors in the brain
    Stockinger, W
    Hengstschläger-Ottnad, E
    Novak, S
    Matus, A
    Hüttinger, M
    Bauer, J
    Lassmann, H
    Schneider, WJ
    Nimpf, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) : 32213 - 32221